Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
Shoko Horita, Motonobu Nakamura, Nobuhiko Satoh, et al.
PPAR Research (2015) Vol. 2015, pp. 1-7
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Open Access | Times Cited: 291
Review of the Structural and Dynamic Mechanisms of PPARγPartial Agonism
Alice J. Kroker, John B. Bruning
PPAR Research (2015) Vol. 2015, pp. 1-15
Open Access | Times Cited: 178
Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée
Cells (2019) Vol. 8, Iss. 7, pp. 726-726
Open Access | Times Cited: 80
Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach
Enrico D’Aniello, Tariq G. Fellous, Fabio Arturo Iannotti, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2019) Vol. 1863, Iss. 3, pp. 586-597
Closed Access | Times Cited: 62
Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment
Milton Packer
European Journal of Heart Failure (2019) Vol. 22, Iss. 2, pp. 214-227
Open Access | Times Cited: 56
The therapeutic potential of inhibiting PPARγ phosphorylation to treat type 2 diabetes
Rebecca L. Frkic, Katharina Richter, John B. Bruning
Journal of Biological Chemistry (2021) Vol. 297, Iss. 3, pp. 101030-101030
Open Access | Times Cited: 51
PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer
Sangeeta Ballav, Bini Biswas, Vishal Kumar Sahu, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3215-3215
Open Access | Times Cited: 29
Consensus statement on dose modifications of antidiabetic agents in patients with hepatic impairment
KalyanKumar Gangopadhyay, Parminder Singh
Indian Journal of Endocrinology and Metabolism (2017) Vol. 21, Iss. 2, pp. 341-341
Open Access | Times Cited: 54
Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction
Milton Packer
Journal of Cardiac Failure (2019) Vol. 25, Iss. 12, pp. 986-1003
Closed Access | Times Cited: 51
Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones
Diana Alemán-González-Duhart, Feliciano Tamay‐Cach, Samuel Álvarez-Almazán, et al.
PPAR Research (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 49
Cardiac Insulin Resistance in Heart Failure: The Role of Mitochondrial Dynamics
Masao Saotome, Takenori Ikoma, Prottoy Hasan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3552-3552
Open Access | Times Cited: 49
Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
Dorrin Zarrin Khat, Mansoor Husain
Current Diabetes Reports (2018) Vol. 18, Iss. 7
Closed Access | Times Cited: 48
Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways
Shabnoor Iqbal, Farhat Jabeen, Ivan Kahwa, et al.
Cardiovascular Toxicology (2023) Vol. 23, Iss. 9-10, pp. 295-304
Open Access | Times Cited: 15
Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas
Henrique Souza-Tavares, Carolline Santos Miranda, Isabela Macedo Lopes Vasques‐Monteiro, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4136-4155
Open Access | Times Cited: 14
Role of epicardial adipose tissue in heart failure with preserved ejection fraction: An emerging molecular mechanism and therapeutic potential
Zhongwen Qi, Dan Wu, Zhipeng Yan, et al.
Obesity Reviews (2025)
Open Access
Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents
Mohd. Javed Naim, Ozair Alam, Md. Jahangir Alam, et al.
Bioorganic Chemistry (2017) Vol. 76, pp. 98-112
Closed Access | Times Cited: 47
Thiazolidinedione derivatives: emerging role in cancer therapy
Ganesh Latambale, Kapil Juvale
Molecular Diversity (2025)
Closed Access
Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system
Barbara Toffoli, Federica Gilardi, Carine Winkler, et al.
PLoS ONE (2017) Vol. 12, Iss. 2, pp. e0171474-e0171474
Open Access | Times Cited: 33
Rosiglitazone promotes ENaC-mediated alveolar fluid clearance in acute lung injury through the PPARγ/SGK1 signaling pathway
Jing He, Di Qi, Xumao Tang, et al.
Cellular & Molecular Biology Letters (2019) Vol. 24, Iss. 1
Open Access | Times Cited: 32
Deciphering the Roles of Thiazolidinediones and PPARγin Bladder Cancer
Melody Chiu, Lucien McBeth, Puneet Sindhwani, et al.
PPAR Research (2017) Vol. 2017, pp. 1-9
Open Access | Times Cited: 25
Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension
Alexandre Vallée, Bernard L. Lévy, Jacques Blacher
Current Hypertension Reports (2018) Vol. 20, Iss. 7
Closed Access | Times Cited: 25
Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study
Fabio Arturo Iannotti, Fabrizia De Maio, Elisabetta Panza, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1119-1119
Open Access | Times Cited: 22
Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin
Bindu Chamarthi, Anthony H. Cincotta
Postgraduate Medicine (2017) Vol. 129, Iss. 4, pp. 446-455
Open Access | Times Cited: 24
Ultrasound Stimulation Potentiates Management of Diabetic Hyperglycemia
Chia-Hsuan Chang, Kang‐Chih Fan, Yuan-Pin Cheng, et al.
Ultrasound in Medicine & Biology (2023) Vol. 49, Iss. 5, pp. 1259-1267
Closed Access | Times Cited: 6
Time-dependent therapeutic roles of nitazoxanide on high-fat diet/streptozotocin-induced diabetes in rats: effects on hepatic peroxisome proliferator-activated receptor-gamma receptors
Samah M. Elaidy, Mona A. Hussain, Mohamed K. El-Kherbetawy
Canadian Journal of Physiology and Pharmacology (2017) Vol. 96, Iss. 5, pp. 485-497
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top